Hypertension: reflections on risks and prognostication
- PMID: 19427490
- PMCID: PMC3719976
- DOI: 10.1016/j.mcna.2009.02.006
Hypertension: reflections on risks and prognostication
Abstract
Framingham Heart Study cardiovascular disease prospective population epidemiologic research has played an important role in the evolution of modern cohort study design and the advancement of preventive cardiology. To date no single essential factor has been identified; multiple interrelated factors are promoting increased risk for development of CHD. Elevated blood pressure has emerged as a prominent member of cardiovascular risk factors. The study's documentation of a strong link of blood pressure to development of cardiovascular events stimulated the pharmaceutical industry to develop medications for controlling blood pressure and, in turn, national campaigns to combat hypertension and its adverse vascular outlook.
Figures
References
-
- Kannel WB, Dawber TR, et al. Factors of Risk in the Development of Coronary Heart Disease- Six-Year Follow-up Experience. The Framingham Study. An Intren Med. 1961;55:33–50. - PubMed
-
- Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res. 1995;18:181–196. - PubMed
-
- Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham Study. Am J Cardiol. 1971;27:335–345. - PubMed
-
- Kannel WB, Dawber TR, McGee DL, et al. Perspectives on systolic hypertension: the Framingham Study. Circulation. 1980;61:1179–1182. - PubMed
-
- Port S, Demer L, Jennrich R, Walter D, Garfinkel A. Systolic blood pressure and mortality. Lancet. 2000;355:175–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
